Imlunestrant (Synonyms: LY-3484356) |
| Catalog No.GC69268 |
Imlunestrant (LY-3484356) is an orally effective and selective estrogen receptor (ER) degrader (SERD) with pure antagonistic properties. Imlunestrant can sustainably inhibit ER-dependent gene transcription and cell growth. Imlunestrant can be used in the research of ER-positive (ER+) advanced breast cancer (aBC) and endometrial endometrioid carcinoma (EEC).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2408840-26-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Imlunestrant
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Imlunestrant
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *